NFE2L2 and cancer: DMF was first shown to possess cytoprotective and antioxidant effects in non-cancer models, which appeared to be related to the induction of the nuclear factor erythroid 2 (NF-E2)-related factor 2 (NRF2) pathway which also crosstalks with the NF-κB pathway [8,9,10,11,12,13].